Andrew Yule Company Ltd vs Indrayani Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Apr 20, 2026

Key Highlights

The Latest Trading Price of Andrew Yule & Company Ltd is ₹ 20.82 as of 20 Apr 15:30 . The P/E Ratio of Andrew Yule & Company Ltd changed from 27.4 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Indrayani Biotech Ltd changed from 23.5 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 years The Market Cap of Andrew Yule & Company Ltd changed from ₹ 965.68 crore on March 2021 to ₹ 1258 crore on March 2025 . This represents a CAGR of 5.44% over 5 yearsThe Market Cap of Indrayani Biotech Ltd changed from ₹ 21.73 crore on March 2021 to ₹ 64.93 crore on March 2025 . This represents a CAGR of 24.47% over 5 years The revenue of Andrew Yule & Company Ltd for the Dec '25 is ₹ 84.64 crore as compare to the Sep '25 revenue of ₹ 82.52 crore. This represent the growth of 2.57% The revenue of Indrayani Biotech Ltd for the Dec '25 is ₹ 35.85 crore as compare to the Sep '25 revenue of ₹ 37.75 crore. This represent the decline of -5.03% The ebitda of Andrew Yule & Company Ltd for the Dec '25 is ₹ -4.13 crore as compare to the Sep '25 ebitda of ₹ 6.39 crore. This represent the decline of -164% The ebitda of Indrayani Biotech Ltd for the Dec '25 is ₹ 3.62 crore as compare to the Sep '25 ebitda of ₹ 4.25 crore. This represent the decline of -14.82% The net profit of Andrew Yule & Company Ltd changed from ₹ -12.35 crore to ₹ -10.56 crore over 7 quarters. This represents a CAGR of -8.56% The net profit of Indrayani Biotech Ltd changed from ₹ 0.85 crore to ₹ 0.12 crore over 7 quarters. This represents a CAGR of -67.33% The Dividend Payout of Andrew Yule & Company Ltd changed from 29.25 % on March 2023 to 0 % on March 2025 . This represents a CAGR of -100.00% over 3 yearsThe Dividend Payout of Indrayani Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Andrew Yule & Company Ltd

Andrew Yule & Company Limited (AYCL) is a nationalized enterprise in the businesses of both manufacturing and sale of Black Tea, Transformers, Regulators/ Rectifiers, Circuit Breakers, Switches, Industrial Fans, Tea Machinery, Turnkey jobs etc.
It has 2 operating units out of which 1 in Kalyani West Bengal and 1 in Chennai, Tamil Nadu, and 12 Tea Estates out of which 7 are situated in Assam and 4 are situated in Dooars and 1 in Darjeeling. Andrew Yule & Company Limited (AYCL) was incorporated on May 26, 1919 as a Private Sector Company to work as Managing Agency. After India gained independence from the British Empire, the Company was converted into Public Limited Company in 1948.
With the abolition of Managing Agency System, the Company lost its traditional business and Government of India acquired the Company in 1979.

About Indrayani Biotech Ltd

Indrayani Biotech Limited was incorporated in 1992.
The Company came out with a public issue in 1994 to part-finance its project to produce cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds.
Presently, the Company is engaged in manufacture of electric motors, generators, transformers and electricity distribution and control apparatus Technical agreements have been signed with Floral Max, Malaysia; for rose cultivation; and with B L McKenzie and Associates, New Zealand, for tissue culture.
The planting material for strawberries has been acquired from the US. The company has signed a test agreement with the Technology Transfer Offer of the University of California to obtain certified planting material from nurseries in California. IBL started exporting flowers to Holland and Dubai during 1994-95.

FAQs for the comparison of Andrew Yule & Company Ltd and Indrayani Biotech Ltd

Which company has a larger market capitalization, Andrew Yule & Company Ltd or Indrayani Biotech Ltd?

Market cap of Andrew Yule & Company Ltd is 1,018 Cr while Market cap of Indrayani Biotech Ltd is 55 Cr

What are the key factors driving the stock performance of Andrew Yule & Company Ltd and Indrayani Biotech Ltd?

The stock performance of Andrew Yule & Company Ltd and Indrayani Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Andrew Yule & Company Ltd and Indrayani Biotech Ltd?

As of April 20, 2026, the Andrew Yule & Company Ltd stock price is INR ₹20.82. On the other hand, Indrayani Biotech Ltd stock price is INR ₹12.08.

How do dividend payouts of Andrew Yule & Company Ltd and Indrayani Biotech Ltd compare?

To compare the dividend payouts of Andrew Yule & Company Ltd and Indrayani Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.